[ASAP] Combinational Chemoimmunotherapy for Breast Cancer by Codelivery of Doxorubicin and PD-L1 siRNA Using a PAMAM-Incorporated Liposomal Nanoplatform

ACS Applied Materials& InterfacesDOI: 10.1021/acsami.1c21775

Source: ACS Applied Materials and Interfaces - February 9, 2022 Category: Materials Science Authors: Qing Hu, Jiayi Yao, Xiaoqin Wang, Yanfang Wang, Xiaoling Fu, Ju Ma, Han Lin, Jiaqi Xu, Longhua Shen, and Xiangbin Yu Source Type: research